EBF3, EBF transcription factor 3, 253738

N. diseases: 124; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
0.700 GeneticVariation disease UNIPROT De Novo Mutations in EBF3 Cause a Neurodevelopmental Syndrome. 28017370 2017
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
0.700 GeneticVariation disease UNIPROT A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3. 28017372 2017
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
0.700 GeneticVariation disease UNIPROT Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism. 28017373 2017
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
0.700 GeneticVariation disease CLINVAR
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
0.700 Biomarker disease GENOMICS_ENGLAND
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
0.700 Biomarker disease CTD_human
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
0.700 Biomarker disease GENOMICS_ENGLAND
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME
0.700 CausalMutation disease CLINVAR
CUI: C1535926
Disease: Neurodevelopmental Disorders
Neurodevelopmental Disorders
0.130 Biomarker group BEFREE However, human neurodevelopmental disorders related to EBF3 have not been reported. 28017372 2017
CUI: C1535926
Disease: Neurodevelopmental Disorders
Neurodevelopmental Disorders
0.130 GeneticVariation group BEFREE Our findings demonstrate that variants disrupting EBF3-mediated transcriptional regulation cause intellectual disability and developmental delay and are present in ∼0.1% of individuals with unexplained neurodevelopmental disorders. 28017373 2017
CUI: C1535926
Disease: Neurodevelopmental Disorders
Neurodevelopmental Disorders
0.130 GeneticVariation group BEFREE Mutations in early B cell factor 3 (<i>EBF3</i>) were recently described in patients with a neurodevelopmental disorder (NDD) that includes developmental delay/intellectual disability, ataxia, hypotonia, speech impairment, strabismus, genitourinary abnormalities, and mild facial dysmorphisms. 29062322 2017
CUI: C1535926
Disease: Neurodevelopmental Disorders
Neurodevelopmental Disorders
0.130 CausalMutation group CLINVAR
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.120 AlteredExpression disease BEFREE Our findings demonstrate that variants disrupting EBF3-mediated transcriptional regulation cause intellectual disability and developmental delay and are present in ∼0.1% of individuals with unexplained neurodevelopmental disorders. 28017373 2017
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.120 CausalMutation disease CLINVAR A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3. 28017372 2017
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.120 GeneticVariation disease BEFREE Mutations in early B cell factor 3 (<i>EBF3</i>) were recently described in patients with a neurodevelopmental disorder (NDD) that includes developmental delay/intellectual disability, ataxia, hypotonia, speech impairment, strabismus, genitourinary abnormalities, and mild facial dysmorphisms. 29062322 2017
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.120 Biomarker disease HPO
CUI: C0004134
Disease: Ataxia
Ataxia
0.110 CausalMutation phenotype CLINVAR A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3. 28017372 2017
CUI: C0004134
Disease: Ataxia
Ataxia
0.110 GeneticVariation phenotype BEFREE Mutations in early B cell factor 3 (<i>EBF3</i>) were recently described in patients with a neurodevelopmental disorder (NDD) that includes developmental delay/intellectual disability, ataxia, hypotonia, speech impairment, strabismus, genitourinary abnormalities, and mild facial dysmorphisms. 29062322 2017
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.110 CausalMutation phenotype CLINVAR A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3. 28017372 2017
CUI: C0007758
Disease: Cerebellar Ataxia
Cerebellar Ataxia
0.110 GeneticVariation phenotype BEFREE Mutations in early B cell factor 3 (<i>EBF3</i>) were recently described in patients with a neurodevelopmental disorder (NDD) that includes developmental delay/intellectual disability, ataxia, hypotonia, speech impairment, strabismus, genitourinary abnormalities, and mild facial dysmorphisms. 29062322 2017
CUI: C0038379
Disease: Strabismus
Strabismus
0.110 GeneticVariation disease BEFREE Mutations in early B cell factor 3 (<i>EBF3</i>) were recently described in patients with a neurodevelopmental disorder (NDD) that includes developmental delay/intellectual disability, ataxia, hypotonia, speech impairment, strabismus, genitourinary abnormalities, and mild facial dysmorphisms. 29062322 2017
CUI: C0038379
Disease: Strabismus
Strabismus
0.110 CausalMutation disease CLINVAR A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3. 28017372 2017
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.110 AlteredExpression group BEFREE Our findings demonstrate that variants disrupting EBF3-mediated transcriptional regulation cause intellectual disability and developmental delay and are present in ∼0.1% of individuals with unexplained neurodevelopmental disorders. 28017373 2017
CUI: C0038379
Disease: Strabismus
Strabismus
0.110 Biomarker disease HPO
CUI: C3714756
Disease: Intellectual Disability
Intellectual Disability
0.110 Biomarker group HPO